Serum S100β as a predictor of severity and outcomes for mixed subtype acute ischaemic stroke.
Serum S100β levels are mostly used for predicting outcomes of large vessel stroke (LVS). Its application for mixed subtypes of acute ischaemic stroke (AIS) is limited. Patients with mixed subtype of AIS, aged over 18 years, who presented within 24 hours of stroke onset were consecutively enrolled. Serum S100β levels at presentation (S100βb) and 72 hours (S100β72hrs), and corresponding National Institutes of Health Stroke Scale (NIHSSb and NIHSS72hrs, respectively) were assessed. Stroke outcomes were evaluated by modified Rankin Scale (mRs) at 30 days (mRs30) and 90 days (mRs90). Correlations between S100βb, S100β72hrs and difference between the two (∆S100β) with corresponding NIHSS, mRs30 and mRs90 were evaluated (p < 0.05). For analysis, 35 patients were eligible. On univariate analyses, stroke outcomes had significant association with S100βb, S100β72hrs, NIHSSb, NIHSS72hrs and ∆S100β. Both S100βb and S100β72hrs correlated with corresponding NIHSS values (ρb = 0.51, p < 0.001; ρ72hrs = 0.74, p < 0.001), mRs30 (ρb = 0.58, p < 0.001; ρ72hrs = 0.72, p < 0.001) and mRs90 (ρb = 0.51, p = 0.002; ρ72hrs = 0.68, p < 0.001). Correlations existed between ∆S100β and mRs30 (ρ = 0.74, p < 0.001) and mRs90 (ρ = 0.71, p < 0.001). Practical cut-off points for unfavourable outcomes (mRs 3-6) were S100β72hrs > 0.288 μg/L (sensitivity 92.3%; specificity 86.4%) and ∆S100β > 0.125 μg/L (sensitivity 100%; specificity 1.8%). High serum S100β is associated with unfavourable outcome for mixed subtype AIS. Cut-off values of S100β72hrs and ∆S100β were optimal for predicting unfavourable stroke outcome.